my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Contract Manufacturing (CMO) services for cGMP protein, plasmid, vaccine and conjugates for Phase I, II, III and commercial production. Contact us for your process transfer / development, QC development, GMP manufacturing needs. You'll have access to our significant experience working with E. coli, more
Eurogentec is a leading provider of reliable and innovative products and services to the Life-Science, Diagnostic and Pharmaceutical community. more
Eurogentec S.A. announced a final agreement for the acquisition of AnaSpec Inc. AnaSpec is a provider of integrated proteomics solutions for life science research and diagnostics with expertise in peptides synthesis, labeled peptides and antibodies, fluorescent dyes and enzyme activity assays. “ more
ThromboGenics NV and Geymonat SpA announced that the European Union has approved a Euro 2 million grant to the VASOPLUS consortium, a development programme for a new class of pro-angiogenesis agents. The funded research for VASOPLUS will be conducted within a consortium that will comprise ThromboGen more
EuroGentest announced a series of initiatives following the European Society of Human Genetics in Amsterdam designed to enhance and harmonise genetic testing across the EU. These include piloting the first European-wide cytogenetics EQA scheme, drawing up minimum guidelines on genetic counselling, d more
When working with DNA and oligo samples great care needs to be taken at every stage to ensure that degradation does not occur, and the highly potent samples are not contaminated. Use of state of the art concentration systems can significantly speed up concentration rates, saving researchers time, and also eliminate potential sources of damage to samples more
Personalized Nursing Services SA (PNS) is a healthcare service provider that is focused on the provision of paramedical care at patients' home and in residential centers. The company services include residential services for disabled children and adults, and accommodation centers for disabled adults more
How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects for RNAi-based therapeutics. We aim to save you time and aid your decisions through our research, dat more
Home Company Prodotti Genomics PCR Sintesi Oligonucleotidi Taq Polimerasi Taq Polimerasi IVD Nano Volume DNA/RNA Quantification Epigenetics Sistemi sonicazione Bioruptor Accessori Bioruptor Kits Molecular Imaging Gel Logic Slite 140 Image Station IS 4000 In Vivo Specimen Radiography Partners Supplie more
glossary media library contact us close Latest News Novartis Exercises its Right to Purchase Additional Shares of Alnylam Common Stock Alnylam Completes Key Technology Transfer Objectives in its Takeda Alliance and Earns $20 Million Payment InterfeRx ™ & Reagent Licenses In addition more
Home Services Courses Research Webshop About tataa Contact CTC Diagnostics About TATAA Courses Course registration Instructors Course Modules Custom Made Downloads Partners Frequently Asked Questions Courses in collaboration with TESTIMONIALS Partners Instrument Agilent Technologies BIOplastics BIOp more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
